Using Synthetic Antibody to Limit COVID-19 Spread

Governments and companies have started distributing a few varieties of COVID-19 vaccines around the globe. Even so, researchers at the University of California (UCSF) have formulated an innovative method that may provide a somewhat more effective way to curb the development of coronavirus inside the human body.

The researchers developed an artificial antibody that keeps the COVID-19 virus from sticking to human cells. These artificial antibodies are based on the microscopic antibodies that are produced by animals like llamas and camels, to defend themselves from coronavirus varieties.

The antibodies attack the spikes found on the exterior of the COVID-19 virus, which is used by the virus to bind itself to human cells. By targeting these spikes, antibodies obstruct the virus’s ability to bind to cells.

According to the researchers, these synthetic antibodies can be generated in large quantities using microbes or bacteria and then dried in a powder form for storage purposes.

The powder can then be inhaled directly into the lungs through a nebulizer, providing adequate protection against the recurring COVID-19 virus. Clinical trials, however, are still required to validate the method.

Leave a Reply

Your email address will not be published.